Altana's ciclesonide NDA accepted for review

FDA accepted for filing an NDA for ciclesonide nasal spray from Altana (FSE:ALT; AAA) to treat nasal symptoms associated with seasonal and perennial allergic rhinitis. The PDUFA date is Oct. 22. ALT a...